Quarterly value and number of LSHC merger and acquisition deals in China 2019-2021
In the first quarter of 2021, the number of M&A deals in China's life science and healthcare sector amounted to 34 with a combined value of almost four billion U.S. dollars. 2020, the year of the coronavirus outbreak, experienced a high M&A activity in China as a result of favorable policies. The total merger and acquisition deal volume in 2020 was 169 deals.